Victory Capital Management Inc. Has $671,000 Stock Position in USANA Health Sciences, Inc. (NYSE:USNA)

Victory Capital Management Inc. lessened its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 3.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 17,696 shares of the company’s stock after selling 614 shares during the quarter. Victory Capital Management Inc. owned approximately 0.09% of USANA Health Sciences worth $671,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of USNA. Pzena Investment Management LLC lifted its stake in shares of USANA Health Sciences by 24.4% during the 2nd quarter. Pzena Investment Management LLC now owns 976,633 shares of the company’s stock worth $44,183,000 after buying an additional 191,289 shares during the last quarter. Pacer Advisors Inc. lifted its position in USANA Health Sciences by 14.3% during the second quarter. Pacer Advisors Inc. now owns 467,352 shares of the company’s stock worth $21,143,000 after acquiring an additional 58,597 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its holdings in shares of USANA Health Sciences by 14,068.2% during the third quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock worth $1,472,000 after acquiring an additional 38,547 shares during the period. Assenagon Asset Management S.A. grew its position in shares of USANA Health Sciences by 32.9% in the second quarter. Assenagon Asset Management S.A. now owns 109,252 shares of the company’s stock valued at $4,943,000 after purchasing an additional 27,053 shares during the last quarter. Finally, Deerfield Management Company L.P. Series C increased its stake in shares of USANA Health Sciences by 297.0% during the second quarter. Deerfield Management Company L.P. Series C now owns 29,742 shares of the company’s stock worth $1,346,000 after purchasing an additional 22,251 shares during the period. Institutional investors and hedge funds own 54.25% of the company’s stock.

USANA Health Sciences Stock Performance

NYSE:USNA opened at $39.16 on Friday. The firm has a market cap of $746.39 million, a price-to-earnings ratio of 13.84, a P/E/G ratio of 1.36 and a beta of 0.89. USANA Health Sciences, Inc. has a 52 week low of $34.15 and a 52 week high of $54.81. The firm’s 50-day simple moving average is $37.81 and its 200 day simple moving average is $41.57.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.07. The company had revenue of $200.22 million during the quarter, compared to the consensus estimate of $208.45 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. During the same period in the previous year, the business earned $0.59 earnings per share. Sell-side analysts anticipate that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, DA Davidson reduced their price target on USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating for the company in a research note on Wednesday, October 23rd.

Insider Activity

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 675 shares of the firm’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $37.71, for a total value of $25,454.25. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 0.33% of the company’s stock.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.